I understand that it was a financial news report. Regardless of who the statement was directed at, the patient should never be left out of any statement when it comes to side effects and problems with a drug. They should always come first. Elan and Biogen would do well to remember that, and to emphasize it in every statement they make, and I for one will remind them at every opportunity.

I do not ever forget that if it wasn't for us, they wouldn't have a drug on the market, nor would they be making what amounts to over a billion dollars a year at this point in sales of this drug. I do not ever forget that while they may have to spoonfeed investors, the very people who are taking the drug are the most at risk and what those patients are risking means a whole hell of a lot more than money, and both Elan and Biogen should remember that too, as should every other drug company out there that markets a drug and makes money from it.